Key Takeaways
- Premiumization drove margin expansion: Focused Maharatnas and Maharatna products grew ~20%, shifting the mix from generic supplier to solution provider and helping EBITDA margin improve more than 120 bps YoY.
- Demand outstrips supply: All factories ran at 100% capacity in Q1, with July and August demand described as immense; the company could not fulfill all market demand.
- New launches are scaling fast: Last year's ~1 dozen product launches delivered INR42 crores in Q1 alone, already exceeding the INR34 crores they generated in the entire previous fiscal.
- Q2 faces a sales return headwind: An expected INR60-70 crores in sales returns from Q1 soybean herbicide products will hit Q2, though a provision has already been made and the company is trying to replace that revenue with other products.
- What to watch next quarter: Whether the INR60-70 crore sales return is fully offset by rice herbicides, insecticides and fungicides; the pace of Altair acreage expansion in rabi; and any disclosure on the signed-but-unnamed contracts with at least two companies.
Premiumization & Margin Story
- Strategy working as designed: Premium products grew ~20% while the company simultaneously cut low-margin generic tail products that were not delivering desired results. The combined effect expanded EBITDA margin by more than 120 bps YoY.
- Margin sustainability: Management stated the Q1 EBITDA margin level looks sustainable for the full year and is sticking to a target of more than 100 bps improvement.
- B2C vs B2B mix shift: B2C business grew ~12% while B2B sales fell 8%-9%. B2C carries higher selling expenses (crop advisors, farmer training, retailer/distributor work); in B2B, those costs are shared with partners, though B2B margins are lower unless selling new-generation technology.
- Mix target undisclosed: Management declined to give a B2C/B2B percentage split for FY26, saying B2B business should also grow.
Rajesh Aggarwal: "So I can say that the premiumization strategy has worked out very well because along with the premiumization, we have also worked in the tail cutting."
Demand & Capacity Constraints
- Factories maxed out: All factories are running at 100% capacity and the company cannot fulfill market demand. July and August demand is immense, and meeting demand at the right time and place is a challenge.
- Monsoon was a mixed bag: Early onset and healthy reservoir levels helped rice and maize, which are doing wonderfully well and expected to touch all-time highs. But uneven distribution with dry and wet spells hurt herbicide demand in dry crops like cotton and soybean.
- Inventory light in the channel: No heavy inventory position in the market; demand is good across the country. Company policy is to pick up any leftover Q1 inventory of two herbicides from the market in Q2 itself.
- Sales return from soybean: Q1 was a disaster particularly in soybean. The company expects INR60-70 crores in sales returns in Q2, with a provision already made. The entire return will happen mostly in August, and the company is trying to replace that revenue with rice herbicides, insecticides and fungicides.
Rajesh Aggarwal: "At this moment, with all the factories running at 100% capacity, we are not able to fulfill the market demand. Demand is like that."
New Product Pipeline & Launches
- Last year's launches outperforming: Approximately one dozen products launched last year generated INR42 crores in Q1 alone, exceeding the INR34 crores total for the full previous fiscal. Launches were timed as registrations came, not waiting for season.
- Altair (Nissan patented herbicide): New-generation rice herbicide placed in more than 900 villages. This kharif, taking it to a few thousand acres; rabi acreage will be higher. Maturity target is roughly 0.05 crore acres in 2-3 years. Early user satisfaction has hit the 100% target.
- SPARCLE (Corteva tie-up): Product for rice, launched in August (Q2).
- OAT Agrio JV pipeline: About a dozen patents filed. First product filing planned in 2025, launch in 2026. Second product under development with costing work underway: bringing prices from ~INR10 lakhs per litre down to ~INR5,000, a process taking 1-2 years. Third and fourth products have visibility. IIL has more than 90% probability of manufacturing for the entire world, with exclusive rights for the Indian subcontinent and some Middle East/Africa countries.
- Undisclosed contracts signed: Agreements signed with at least two companies, but management cannot declare details until products are launched.
- Upcoming crop focus: New products will primarily target rice, corn, soybean, wheat, sugarcane, horticulture and pulses.
Dushyant Sood: "What we are aiming right now is 100% satisfaction of 100% users across the geographies where the product has gone. And I'm very pleased to share that the satisfaction level has hit the target."
Capex & Manufacturing
- Dahej Phase 1 complete: The technical plant has started production, adding almost 100 reactors. The asset has just been capitalized; depreciation will be visible at year-end.
- Sotanala timeline: Formulation unit targeted to start in the next kharif season. Technical plant Phase 1 targeted by the end of the next fiscal.
- Kaeros merger: Recently started operations, making products for some companies and for IIL. Targeting about INR100 crores business in FY26, scaling to INR150-200 crores in FY27. Q1-specific numbers were not provided.
- Import substitution effort: Continuously working on backward integration to reduce imports, but not able to go below INR500 crores.
Raw Materials & Cost Environment
- Prices broadly stable: Raw material prices declined after COVID and are now stable, near the bottom. Some small rises occasionally in some products, but fluctuations are minimal and not disruptive.
- Kharif preparedness: Well placed for raw materials till October. For the rabi season, one or two key raw materials have already been bought. The trend beyond that is very difficult to predict.
Rajesh Aggarwal: "The first costings you get are about INR10 lakhs per litre and the target you get is to make it INR5,000. So that's a real war, which happens in India and Japan actually, and it takes about 1 to 2 years in development of bringing those prices to that level and then you can take the product to the market."
Competitive Positioning
- South India strength: Management stated the company is one of the strongest in South India, claiming that three named competitors (India Pesticides, Best Agro, Shivalik Rasayan) combined cannot compete with IIL there.
- No like-for-like comparisons offered: Management declined to compare itself with specific peers, saying it does not like to comment on others.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Q2 revenue | Plus/minus Q1, broadly a repeat of Q1 | Q2 FY26 |
| Sales return | INR60-70 crores from Q1 soybean products, provision made | Mostly in August (Q2 FY26) |
| EBITDA margin improvement | More than 100 bps improvement; Q1 level sustainable for the year | FY26 |
| Premium products growth | Decent double-digit growth maintained | FY26 |
| B2C growth | Double-digit growth; 20% growth from premium products | FY26 |
| Kaeros revenue | ~INR100 crores | FY26 |
| Kaeros revenue | INR150-200 crores | FY27 |
| Sotanala formulation unit | Start production | Next kharif season |
| Sotanala technical plant Phase 1 | Start production | End of next fiscal |
| Altair acreage | Few thousand acres in kharif; more in rabi | FY26 |
| Altair maturity volumes | Roughly 0.05 crore acres | 2-3 years |
| OAT JV first product filing | Filing planned | Calendar year 2025 |
| OAT JV first product launch | Launch | Calendar year 2026 |
| OAT JV second product costing | Bring from ~INR10 lakhs/litre to ~INR5,000 level | 1-2 years |
| New product launches | Lot of launches expected | This year and next fiscal |
| Professional hiring | Some joining before Diwali, some after | FY26 |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Revenue | ₹691 cr, +5% YoY from ₹657 cr |
| Gross profit | ₹202 cr, 29.2% margin vs 27.6% YoY |
| EBITDA | ₹85 cr, +122 bps YoY from ₹72 cr |
| EBITDA margin | ~12%, vs ~11% in Q1 FY25 |
| PAT | ₹42 cr, +18% YoY |
| Premium products growth | ~20% YoY |
| Premium products share | 58% of sales; other products 42% |
| B2C sales share | 75% of total sales; B2B 23%, exports 2% |
| B2C growth | ~12% YoY |
| B2B growth | -8% to -9% YoY |
| Sales from FY25 launches | ₹42 cr in Q1, vs ₹34 cr in all of FY25 |
| Crop advisors deployed | 1,300+, vs 900 normally |
| Expected Q2 sales return | ₹60–70 cr provisioned, pertaining to Q1 products |
| Kaeros FY26 target | ~₹100 cr |